DrugPatentWatch Database Preview
« Back to Dashboard
Atracurium Besylate is a drug marketed by Aurobindo Pharma Ltd, Baxter Hlthcare, Baxter Hlthcare Corp, Hospira, Hospira Inc, Mylan Labs Ltd, Nanjing King-friend, Teva Parenteral, Watson Pharms Teva, West-ward Pharms Int, and Watson Labs Inc. and is included in twenty-two NDAs.
The generic ingredient in ATRACURIUM BESYLATE is atracurium besylate. There are sixteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the atracurium besylate profile page.